Go Pro

Damora Therapeutics, Inc. Common Stock (DMRA) Earnings Date, Estimates & Call Transcripts

Damora Therapeutics, Inc. Common Stock logo
$29.54 -0.38 (-1.27%)
As of 04:00 PM Eastern

Damora Therapeutics, Inc. Common Stock Earnings Summary

Damora Therapeutics, Inc. Common Stock released Q1 2026 earnings on May 13, 2026, reporting an EPS of -$0.62, which missed the consensus estimate of -$0.39 by $0.23. With a trailing EPS of -$5.58, Damora Therapeutics, Inc. Common Stock's earnings are expected to decrease next year, from ($1.92) to ($2.08) per share.

Latest Q1
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$0.39
Actual EPS
(May. 13)
-$0.62 Missed By -$0.23

Q1 2026 Earnings Resources

Get Damora Therapeutics, Inc. Common Stock Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Damora Therapeutics, Inc. Common Stock and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

DMRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Damora Therapeutics, Inc. Common Stock Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$0.32-$0.32-$0.32
Q3 20261-$0.33-$0.33-$0.33
Q4 20261-$0.34-$0.34-$0.34
2026 3 -$0.99 -$0.99 -$0.99
Q1 20271-$0.35-$0.35-$0.35
Q2 20271-$0.37-$0.37-$0.37
Q3 20271-$0.40-$0.40-$0.40
Q4 20271-$0.42-$0.42-$0.42

Damora Therapeutics, Inc. Common Stock Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026-$0.4470-$0.39+$0.0570-$0.39--
5/13/2026Q1 2026-$0.3878-$0.62 -$0.2322-$0.62--
11/6/2025Q3 2025--$2.36--$2.36--
8/5/2025Q2 2025--$2.60--$2.60--
5/8/2025Q1 2025--$1.92--$1.92--
3/19/2025Q4 2024-$3.12-$5.22 -$2.10-$5.22--
8/12/2024--$8.00-$4.00+$4.00-$0.12--

Damora Therapeutics, Inc. Common Stock Earnings - Frequently Asked Questions

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) last announced its quarterly earning data on Monday, August 10, 2026. Learn more on DMRA's earnings history.

In the previous quarter, Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) reported ($0.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.06. Learn more on analysts' earnings estimate vs. DMRA's actual earnings.

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) has a recorded net income of -$209.84 million. DMRA has generated -$5.58 earnings per share over the last four quarters.

Damora Therapeutics, Inc. Common Stock's earnings are expected to decrease from ($1.92) per share to ($2.08) per share in the next year.


Earnings data for NASDAQ:DMRA is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners